Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib and Revlimid in Relapsed/Progressive Multiple Myeloma
NCT00093028Phase 3Completed
- Sponsor
- University of Arkansas
- Start
- Jan 2004
- Primary completion
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lenalidomide in multiple myeloma (MM), sponsored by University of Arkansas. Started Jan 2004; status: completed.
02
Drugs
lenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00093028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00093028.